Results

Total Results: over 10,000 records

Showing results for "drugs".

341. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Boston (MA): Vertex Pharmaceuticals, Inc.; 2014 Nov 05 [accessed 2014 Dec 11]. [3 p]. … Boston (MA): Vertex Pharmaceuticals Incorporated [accessed 2015 Dec 10]. [2 p]. … MannKind Corporation, Takeda Pharmaceuticals America, Inc, Genentech USA, Inc. … Boehringer Ingelheim Pharmaceuticals, Inc. … Ridgefield (CT): Boehringer Ingelheim Pharmaceuticals, Inc.; 2014 Oct. 18 p.

342. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/60248/psn-pdf
     April 22, 2020 - been removed from the original container; this was more likely in incidents involving prescription drugs … compared to OTC drugs (adjusted odds ratio, 3.39; 95% CI, 2.87-4.00).  

343. Average Annual Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2021-2022
     meps.ahrq.gov/data_files/publications/st559/stat559.shtml
     February 01, 2025 - share of spending financed by private insurance / TRICARE was larger for all prescription drugs … than for opioids (27.4 percent) while the Medicare share of spending was similar for all drugs … combined to finance about three-quarters of the payments for all outpatient prescription drugs … The share of spending financed by private insurance / TRICARE was larger for all prescription drugs ( … Additionally, NSDUH employs targeted questions with show cards for specific drugs, utilizes

344. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
     November 03, 2011 - The FDA has approved no drugs for migraine prevention in children. … prevention, which include novel antiepileptic drugs, calcium channel modulators, glutamate blockers … o Use of drugs for acute migraine (prescribed or over-counter). … Drugs approved by the FDA for migraine prevention and off-label drugs examined in clinical trials. … Studies that examined eligible drugs on populations with other diseases.

345. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … Treatment with the class of agents known as disease-modifying anti- rheumatic drugs (DMARDs) has become … , which are created by biologic processes, or non-biologic drugs, which are manufactured chemically. … Furthermore, it is possible that the effectiveness of these drugs varies by category of JIA. … be used for difficult-to-treat JIA, or the impact of using multiple drugs.

346. Screening for Unhealthy Drug Use: Clinician Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/tpCHxaLN8aUUEWELwGmFLd
     June 01, 2020 - Unhealthy drug use includes using illegal drugs, such as heroin, or using a prescription drug in ways … Quick Screen, which asks 4 questions about use of alcohol, tobacco, nonmedical use of prescription drugs … , and illegal drugs in the past year), which may be more feasible in busy primary care settings

347. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Given the limited pharmacologic treatment options for obesity, additional pharmaceuticals intended … San Diego (CA): Arena Pharmaceuticals, Inc; 2010 Nov 09 [accessed 2011 Dec 16]. [3 p]. … Washington (DC): Arena Pharmaceuticals, Inc.; 2009 Oct 27 [accessed 2011 Apr 21]. [4 p]. … San Diego (CA): Arena Pharmaceuticals, Inc.; 2010 Jul 01 [accessed 2014 Apr 29]. [3 p]. … San Diego (CA): Arena Pharmaceuticals; 2012 Jun 27 [accessed 2012 Jul 05]. [4 p].

348. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49426/psn-pdf
     November 01, 2003 - right after admission, it would have been appropriate to administer one of the atypical antipsychotic drugs … The distinction between typical and atypical antipsychotic drugs relates to their capacity to cause … extrapyramidal symptoms (EPS); the atypical drugs are much less likely to produce these adverse effects … dopaminergic and cholinergic systems required for normal motor behavior [5]), atypical antipsychotic drugs … QTc interval is 440 ms or longer, and patients have electrolyte disturbance or are receiving other drugs

349. Drug shortages: a complex health care crisis. | PSNet
     psnet.ahrq.gov/issue/drug-shortages-complex-health-care-crisis
     September 12, 2016 - September 6, 2023 Nearly all thirty most frequently used emergency department drugs experienced … April 27, 2022 Despite federal legislation, shortages of drugs used in acute care settings … March 29, 2023 Nearly all thirty most frequently used emergency department drugs experienced

350. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/60202/psn-pdf
     April 08, 2020 - inappropriate prescribing were identified, including polypharmacy and use of central nervous system drugs … use-electronic-clinical-decision-support-system-primary-care-assess-inappropriate https://psnet.ahrq.gov/issue/polypharmacy-elderly-when-good-drugs-lead-bad-outcomes-teachable-moment

351. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
     September 01, 2007 - For example, although 15 drugs were withdrawn from the market between 1997 and 2005 based on MedWatch … The surveillance administration process involves the identification of newly introduced drugs that … No effective mechanism currently exists for tracking the purchase of such drugs. … Such dispensation of drugs by the physicians may need to be monitored, especially for drugs that have … In order to cater to this need, all drugs taken by patients will need to be monitored.

352. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
     September 01, 2007 - For example, although 15 drugs were withdrawn from the market between 1997 and 2005 based on MedWatch … The surveillance administration process involves the identification of newly introduced drugs that … No effective mechanism currently exists for tracking the purchase of such drugs. … Such dispensation of drugs by the physicians may need to be monitored, especially for drugs that have … In order to cater to this need, all drugs taken by patients will need to be monitored.

353. S29 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
     October 01, 2007 - it involved 2 short-term drugs instead of 2 long-term drugs? … Changes could also confuse physicians; confusion could generalize beyond the study drugs. … Some leaders noted that newer drugs are not typically included on their formulary. … Including short term drugs would be more challenging. … Make clear that physicians have flexibility to prescribe nonstudy drugs.

354. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
     June 11, 2019 - Persons who inject drugs and have 1 of the following charac- teristics: • Shared use of drug injection … In 1 trial, the Bang- kok Tenofovir Study of persons who inject drugs, there were 7 cases of grade 2 … Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. … Drugs. 2015;75(3):243-251. doi:10.1007/s40265-015- 0355-4 65. … Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection:

355. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
     December 01, 2020 - Points • Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti- inflammatory drugs … Some opioids may be less effective than other drugs. … Results Evidence on triptans and nonsteroidal anti-inflammatory drugs (NSAIDs) was summarized from … In terms of applicability, several of the established drugs, such as the ergot alkaloids, may not be … In general, adverse events of these drugs are mild and transient.

356. Methodology Report #12: Outpatient Prescription Drugs: Data Collection and Editing in the 1996 MEPS (HC-010A)
     meps.ahrq.gov/data_files/publications/mr12/mr12.shtml
     June 01, 2001 - in for pharmacy-reported drugs. … Excluded from the flat files were 899 SF drugs, 6,691 NSF drugs, and 32 PC drugs for … For the 498 PC drugs lacking a GPI code, the 71,159 PC drugs with a valid reported NDC were … Return to Top Unmatched PC Data In the PC donor database of 81,621 drugs (all 84,029 PC drugs … These drugs had an average prescription price of $31.51.

357. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - San Diego (CA): Arena Pharmaceuticals, Inc; 2010 Nov 9 [accessed 2011 Dec 16]. [3 p]. … Washington (DC): Arena Pharmaceuticals, Inc.; 2009 Oct 27 [accessed 2011 Apr 21]. [4 p]. … San Diego (CA): Arena Pharmaceuticals, Inc.; 2009 Dec 22 [accessed 2012 Mar 26]. [2 p]. … San Diego (CA): Arena Pharmaceuticals; 2012 Jun 27 [accessed 2012 Jul 5]. [4 p]. … Arena Pharmaceuticals. Lorcaserin hydrochloride. Drugs Future. 2007;32(9):766-70. 77.

358. Prescribing Safety in Ambulatory Care: Physician Perspectives (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Rundall.pdf
     January 01, 2003 - These examples point to a broader medication management issue, the rapidly increasing array of drugs … available for use by physicians, captured in the following comment: “There are more drugs than ever … Some physicians expressed concern that they were often put in the position of prescribing drugs for … their medications, the physician could prescribe interacting drugs. … The third most commonly cited concern was safety of prescribing drugs for the elderly (11 mentions).

359. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49790/psn-pdf
     April 01, 2017 - Doyle, MBBS Adverse reactions to drugs (including contrast media) occur frequently and were responsible … hospital annually between 1996 and 2000 (Hospital Episode Statistics) in the United Kingdom (UK).(1) All drugs … suspected drug allergy, the following should be documented: generic and proprietary name of the drug or drugs … taken, or number of days on the drug before onset of the reaction; route of administration; and which drugs … the reaction, the drug given, the timeframe of the reaction from initiation of the drug, and what drugs

360. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/41513/psn-pdf
     September 26, 2012 - prospective simulation-based evaluation of aseptic techniques in the administration of anaesthetic drugs … prospective simulation-based evaluation of aseptic techniques in the administration of anaesthetic drugs